MARISSA PREZZEMOLO: Open Payments
NPI 1902418171 · CORAL SPRINGS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,771 in 161 payments from 19 companies in 2025. Trend: 2023 $2,698 · 2024 $3,689 · 2025 $3,771
Food & beverage: $3,671Education: $100
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 47 | $834 |
| Mallinckrodt Hospital Products Inc. | 11 | $463 |
| UCB, Inc. | 21 | $403 |
| Janssen Biotech, Inc. | 12 | $368 |
| Novartis Pharmaceuticals Corporation | 14 | $341 |
| ABBVIE INC. | 13 | $289 |
| GENZYME CORPORATION | 5 | $165 |
| E.R. Squibb & Sons, L.L.C. | 6 | $164 |
| AstraZeneca Pharmaceuticals LP | 6 | $144 |
| GlaxoSmithKline, LLC. | 5 | $142 |
Products named: ENBREL, ACTHAR, Bimzelx, TREMFYA, COSENTYX, EVENITY, KEVZARA, ORENCIA.
Industry payments across FL — which companies pay providers there.
